کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
6086440 | 1207186 | 2013 | 13 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: 12Cost-effectiveness of viral hepatitis B & C treatment 12Cost-effectiveness of viral hepatitis B & C treatment](/preview/png/6086440.png)
With the availability of effective antiviral therapies for chronic viral hepatitis B and C, cost-effectiveness studies have been performed to assess the outcomes and costs of these therapies to support health policy. It is now accepted that treatment of active CHB is cost-effective versus no treatment, although there are a variety of options. And with the new developments around CHC treatment and diagnostic tools it is of interest to both the clinician and policy makers to know both the costs and effects of these choices. The purpose of this article is to provide the reader with an insight into the recent treatment developments and cost-effectiveness issues related to chronic hepatitis B and C treatment, and an overview of recent cost-effectiveness studies evolving around HBV and HCV therapy.
Journal: Best Practice & Research Clinical Gastroenterology - Volume 27, Issue 6, December 2013, Pages 973-985